Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 213

1.

c-Myc-regulated microRNAs modulate E2F1 expression.

O'Donnell KA, Wentzel EA, Zeller KI, Dang CV, Mendell JT.

Nature. 2005 Jun 9;435(7043):839-43.

2.

Cancer genomics: small RNAs with big impacts.

Meltzer PS.

Nature. 2005 Jun 9;435(7043):745-6. No abstract available.

PMID:
15944682
3.

An E2F/miR-20a autoregulatory feedback loop.

Sylvestre Y, De Guire V, Querido E, Mukhopadhyay UK, Bourdeau V, Major F, Ferbeyre G, Chartrand P.

J Biol Chem. 2007 Jan 26;282(4):2135-43.

4.

Disruption of Rb/E2F pathway results in increased cyclooxygenase-2 expression and activity in prostate epithelial cells.

Davis JN, McCabe MT, Hayward SW, Park JM, Day ML.

Cancer Res. 2005 May 1;65(9):3633-42.

5.

MicroRNA let-7a down-regulates MYC and reverts MYC-induced growth in Burkitt lymphoma cells.

Sampson VB, Rong NH, Han J, Yang Q, Aris V, Soteropoulos P, Petrelli NJ, Dunn SP, Krueger LJ.

Cancer Res. 2007 Oct 15;67(20):9762-70.

6.

Different regulation of c-Myc- and E2F-1-induced apoptosis during the ongoing cell cycle.

Hengstschläger M, Hölzl G, Hengstschläger-Ottnad E.

Oncogene. 1999 Jan 21;18(3):843-8.

8.

Tumor-suppressive microRNA-22 inhibits the transcription of E-box-containing c-Myc target genes by silencing c-Myc binding protein.

Xiong J, Du Q, Liang Z.

Oncogene. 2010 Sep 2;29(35):4980-8. doi: 10.1038/onc.2010.241.

PMID:
20562918
9.

Direct regulation of an oncogenic micro-RNA cluster by E2F transcription factors.

Woods K, Thomson JM, Hammond SM.

J Biol Chem. 2007 Jan 26;282(4):2130-4.

10.

Target identification of microRNAs expressed highly in human embryonic stem cells.

Li SS, Yu SL, Kao LP, Tsai ZY, Singh S, Chen BZ, Ho BC, Liu YH, Yang PC.

J Cell Biochem. 2009 Apr 15;106(6):1020-30. doi: 10.1002/jcb.22084.

PMID:
19229866
11.

c-Myc is a critical target for c/EBPalpha in granulopoiesis.

Johansen LM, Iwama A, Lodie TA, Sasaki K, Felsher DW, Golub TR, Tenen DG.

Mol Cell Biol. 2001 Jun;21(11):3789-806.

12.

Down-regulation of c-myc and Cyclin D1 genes by antisense oligodeoxy nucleotides inhibits the expression of E2F1 and in vitro growth of HepG2 and Morris 5123 liver cancer cells.

Simile MM, De Miglio MR, Muroni MR, Frau M, Asara G, Serra S, Muntoni MD, Seddaiu MA, Daino L, Feo F, Pascale RM.

Carcinogenesis. 2004 Mar;25(3):333-41.

PMID:
14604889
13.

p53 represses c-Myc through induction of the tumor suppressor miR-145.

Sachdeva M, Zhu S, Wu F, Wu H, Walia V, Kumar S, Elble R, Watabe K, Mo YY.

Proc Natl Acad Sci U S A. 2009 Mar 3;106(9):3207-12. doi: 10.1073/pnas.0808042106.

14.

Adenovirus E1A oncoprotein liberates c-Myc activity to promote cell proliferation through abating Bin1 expression via an Rb/E2F1-dependent mechanism.

Kinney EL, Tanida S, Rodrigue AA, Johnson JK, Tompkins VS, Sakamuro D.

J Cell Physiol. 2008 Sep;216(3):621-31. doi: 10.1002/jcp.21437.

PMID:
18348166
15.

miR-17-92 cluster microRNAs confers tumorigenicity in multiple myeloma.

Chen L, Li C, Zhang R, Gao X, Qu X, Zhao M, Qiao C, Xu J, Li J.

Cancer Lett. 2011 Oct 1;309(1):62-70. doi: 10.1016/j.canlet.2011.05.017.

PMID:
21664042
16.

Inter- and intra-combinatorial regulation by transcription factors and microRNAs.

Zhou Y, Ferguson J, Chang JT, Kluger Y.

BMC Genomics. 2007 Oct 30;8:396.

17.

E2F1 blocks and c-Myc accelerates hepatic ploidy in transgenic mouse models.

Conner EA, Lemmer ER, Sánchez A, Factor VM, Thorgeirsson SS.

Biochem Biophys Res Commun. 2003 Feb 28;302(1):114-20.

PMID:
12593856
18.

Myc requires distinct E2F activities to induce S phase and apoptosis.

Leone G, Sears R, Huang E, Rempel R, Nuckolls F, Park CH, Giangrande P, Wu L, Saavedra HI, Field SJ, Thompson MA, Yang H, Fujiwara Y, Greenberg ME, Orkin S, Smith C, Nevins JR.

Mol Cell. 2001 Jul;8(1):105-13.

19.

A genetic screen to identify genes that rescue the slow growth phenotype of c-myc null fibroblasts.

Berns K, Hijmans EM, Koh E, Daley GQ, Bernards R.

Oncogene. 2000 Jul 6;19(29):3330-4.

20.

Inactivation of E2f1 enhances tumorigenesis in a Myc transgenic model.

Rounbehler RJ, Rogers PM, Conti CJ, Johnson DG.

Cancer Res. 2002 Jun 1;62(11):3276-81.

Supplemental Content

Support Center